Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.71% | 203.21 | 1.3% | $436.19m | |
| BIIB | Biogen Inc. | 0.73% | 227.72 | 1.3% | $386.27m | |
| GILD | Gilead Sciences, Inc. | 0.08% | 65.35 | 0.9% | $368.51m | |
| CELG | Celgene Corporation | 0.02% | 100.97 | 1.3% | $353.70m | |
| ILMN | Illumina, Inc. | -0.80% | 309.67 | 3.5% | $257.96m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.46% | 299.40 | 2.6% | $220.44m | |
| EXAS | Exact Sciences Corporation | -2.17% | 97.58 | 24.1% | $205.36m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -5.06% | 99.51 | 2.0% | $180.57m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.03% | 176.09 | 1.9% | $177.48m | |
| A | Agilent Technologies, Inc. | -0.65% | 75.26 | 1.6% | $148.26m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.49% | 86.74 | 14.6% | $140.12m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.83% | 67.94 | 4.3% | $95.23m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.05% | 18.87 | 10.2% | $90.77m | |
| SGEN | Seattle Genetics, Inc. | 0.58% | 83.86 | 6.2% | $87.50m | |
| NKTR | Nektar Therapeutics | 1.42% | 17.54 | 5.5% | $85.01m |
Company Profile
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.